Vote number 2005-299 increasing Medicaid rebate for producing generics
on Nov 3, 2005 regarding bill S Amdt 2348 to S 1932 Amendment for Medicaid rebates for generic drugs
Results: Amendment Rejected, 49-50

Vote on an amendment that removes an increase in the Medicaid deduction rebate for generic drugs from 11% to 17%. The effect of the amendment, according to its sponsor, is as follows: "This bill eliminates the ability of generic drugs to be sold using Medicaid. Over half the prescription drugs used in Medicaid are generic. Because we have raised the fees so dramatically on what a generic drug company must pay a pharmacy to handle the drug, pharmacies are not going to use the generic. In the long run, that will cost the Medicaid Program billions of dollars. My amendment corrects that situation." A Senator opposing the amendment said: "This bill has in it already very significant incentives for generic utilization through the way we reimburse generics. Brand drugs account for 67% of Medicaid prescriptions, but they also account for 81% of the Medicaid rebates. This is reasonable policy for us, then, to create parity between brand and generic rebates. This amendment would upset that parity."

Categorized under Health Care

Voting Y counts for 1 points on VoteMatch question 5: More Federal Funding for Health Coverage.